首页 | 本学科首页   官方微博 | 高级检索  
     


Enkephalinase: Selective peptide inhibitors
Authors:Roger L. Hudgin  Stella E. Charleson  M. Zimmerman  R. Mumford  Paul L. Wood
Affiliation:1. Merck Frosst Laboratories, Dept. Pharmacology, Box 1005, Pointe Claire, Que. H9R 4P8, Canada;2. Merck Sharp and Dohme, Dept. Immunology, Rahway, N.J. 07065, USA.
Abstract:A unique, CNS membrane bound enkephalinase is described with greatest activities being measured in the striatum of the mouse. This enzyme was resistant to inhibition by puromycin and bestatin which are potent aminopeptidase inhibitors and to the angiotensin converting enzyme inhibitors, captopril and the free acid of MK-421, which were also very weak inhibitors of aminopeptidase. However, the glycopeptide, phosphoramidon, and the hydroxamic acids, HO-NHCOCH(CH2CH(CH3)2)-CO-Ala-Gly-NH2 and HO-NHCOCH(CH2C6H5)-CO-Ala-Gly-NH2, were potent enkephalinase inhibitors with IC50's (nM) of 39, 3.1 and 8.4, respectively. These peptides remain to be tested invivo.
Keywords:Correspondence: Douglas Hospital Research Centre   6875 Boul. Lasalle   Verdun   Quebec H4H 1R3
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号